>"%s"Allen & Overy

Yondelis v Yloelis: General Court upholds opposition for medicinal product names for use and not for use in oncology (Allen & Overy)

On 16 May 2017, the General Court handed down its decision in Alfa Wasserman SpA (AW) v EUIPO, Pharma Mar intervening (Case T- 85/15).  The decision follows the opposition by Pharma Mar (Pharma), owner of the EU trade mark YONDELIS for pharmaceutical and veterinary products and preparations for use in

Belgium adopts law to prepare for Clinical Trials Regulation implementation (Allen & Overy)

On 20 April 2017, the Law on clinical trials with medicines for human use was adopted to ensure the practical implementation of the EU Clinical Trials Regulation (CTR) in Belgium. The law aims at strengthening Belgium’s position at the forefront of medical research within the EU (Belgium is preceded only

2017-05-12T15:07:10+00:00 12 mai, 2017|Categories: Droit médical Pharma & lifesciences|Tags: , |

Belgium’s absolute advertising prohibition for oral and dental care services incompatible with EU law (Allen & Overy)

On 4 May 2017, the EU Court of Justice (CJEU) ruled that a general and absolute prohibition of any advertising for the provision of oral and dental care services is incompatible with EU law (Case C-339-15). The Court found that Directive 2000/31 on electronic commerce as well as the freedom

2017-05-12T15:05:27+00:00 12 mai, 2017|Categories: Droit médical|Tags: , , |

Aandelenopties : wat blijft er over van het ‘Sinterklaasgeschenk’? (Allen & Overy)

De Administratie heeft op 13 april jl. een nieuw standpunt gepubliceerd inzake aandelen-opties toegekend aan bedrijfsleiders die werkzaam zijn middels een managementvennootschap (Circulaire 2017/C/21). Bijzonder is dat dit gewijzigd standpunt het rechtstreeks gevolg is van de tussenkomst van de minister van Financiën die reageerde op foutieve berichtgeving in de media.

2017-04-27T08:45:32+00:00 27 avril, 2017|Categories: Impôts directs|Tags: , , |

Belgian multiannual framework agreement to streamline delivery of medicines (Allen & Overy)

On 23 March 2017, the Belgian Council of Ministers approved the Multiannual Framework Agreement for Patients (Meerjarenkader voor de patient) that was signed by the Belgian Minister of Health and the Belgian pharmacists associations, APB and OPHACO, on 15 March 2017. The agreement aims to implement optimal pharmaceutical care for

2017-04-13T06:05:48+00:00 13 avril, 2017|Categories: Pharma & lifesciences|Tags: , , |

Use of e-banking secured mailbox to provide information on durable medium (Allen & Overy)

By a decision held on 25 January 2017 (C-375/15), the Court of Justice of the European Union (CJEU) clarified the question of information (in electronic format) that payment service providers (such as banks) convey to their customers to e-banking secured mailboxes as part of an online banking website.

2017-03-10T07:52:20+00:00 10 mars, 2017|Categories: Droit financier|Tags: , , |

The Big Think: Cybersecurity – the threat from within (Allen & Overy)

In this issue ‘Cybersecurity – the threat from within’ we focus on the employment aspects of cybersecurity and ask: what can employers do to build truly secure cyber defences? Are they putting the right resources into training and educating their workforces or relying too much on technology to thwart attacks?